Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 6.04 | -3.67% | -0.23 |
RXRX closed down 3.67 percent on Wednesday, November 20, 2024, on 3.06 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| Volume Surge | Other | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | -3.67% | |
| Bullish Engulfing | Bullish | -3.67% | |
| New 52 Week Low | Weakness | -3.67% | |
| Outside Day | Range Expansion | -3.67% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 19 hours ago |
| Outside Day | about 20 hours ago |
| Fell Below Lower Bollinger Band | about 20 hours ago |
| Fell Below Previous Day's Low | about 20 hours ago |
| New 52 Week Low | about 20 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/06/2024
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 15.74 |
| 52 Week Low | 5.7 |
| Average Volume | 5,548,594 |
| 200-Day Moving Average | 8.34 |
| 50-Day Moving Average | 6.65 |
| 20-Day Moving Average | 6.73 |
| 10-Day Moving Average | 6.83 |
| Average True Range | 0.51 |
| RSI (14) | 40.48 |
| ADX | 17.32 |
| +DI | 20.84 |
| -DI | 25.42 |
| Chandelier Exit (Long, 3 ATRs) | 6.97 |
| Chandelier Exit (Short, 3 ATRs) | 7.22 |
| Upper Bollinger Bands | 7.67 |
| Lower Bollinger Band | 5.78 |
| Percent B (%b) | 0.14 |
| BandWidth | 28.13 |
| MACD Line | -0.07 |
| MACD Signal Line | 0.04 |
| MACD Histogram | -0.1154 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.05 | ||||
| Resistance 3 (R3) | 7.04 | 6.71 | 6.88 | ||
| Resistance 2 (R2) | 6.71 | 6.45 | 6.71 | 6.82 | |
| Resistance 1 (R1) | 6.37 | 6.29 | 6.21 | 6.38 | 6.77 |
| Pivot Point | 6.04 | 6.04 | 5.95 | 6.04 | 6.04 |
| Support 1 (S1) | 5.70 | 5.78 | 5.54 | 5.71 | 5.31 |
| Support 2 (S2) | 5.37 | 5.62 | 5.37 | 5.26 | |
| Support 3 (S3) | 5.03 | 5.37 | 5.20 | ||
| Support 4 (S4) | 5.04 |
